Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.
暂无分享，去创建一个
T. Hickish | W. Greenhalf | Eithne Costello | J. Neoptolemos | D. Cunningham | P. Ghaneh | S. Madhusudan | R. Jackson | D. Palmer | H. Wasan | G. Middleton | F. Campbell | J. Valle | R. Ross | P. Corrie | T. Cox | C. Rawcliffe | D. Propper | J. Wadsley | S. Falk | F. Coxon | A. Evans | V. Shaw | N. Wadd